Tibet Rhodiola Pharmaceutical Holding Co (600211 SHG) stock market data APIs
¥42.0499
-0.27(-0.6%)
as of May 11, 2026
Try our APIs with
free plan!
Tibet Rhodiola Pharmaceutical Holding Co Financial Data Overview
Price chart is built with
Anychart
Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.
Prev. Close
42.0499
Open
41.7845
High
42.1116
Low
41.3299
52 wk Range
35.41-57.98
Market Cap
13 673 M
P/E Ratio
14.14
Shares Outstanding
322 M
Revenue
2 982 M
EPS
1.2229
Dividends (Yield)
0
Beta
0.38
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tibet Rhodiola Pharmaceutical Holding Co (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tibet Rhodiola Pharmaceutical Holding Co data using free add-ons & libraries
Get Tibet Rhodiola Pharmaceutical Holding Co Fundamental Data
Tibet Rhodiola Pharmaceutical Holding Co Fundamental data includes:
- Net Revenue: 2 982 M
- EBITDA: 1 002 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Tibet Rhodiola Pharmaceutical Holding Co Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2023-04-27
- EPS/Forecast: NaN
Get Tibet Rhodiola Pharmaceutical Holding Co End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tibet Rhodiola Pharmaceutical Holding Co News
New
Russia looks to China to help produce its Sputnik V COVID-19 vaccine
It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine, as the U.S. and the European Union focus mainly on domestic vaccination needs.
Russia looks to China to help produce its Sputnik V COVID-19 vaccine
It's a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia's vaccine, as the U.S. and the European Union focus mainly on domestic vaccination needs.
China's Rhodiola set to sell and test Russia's Sputnik-V vaccine
HONG KONG/BEIJING (Reuters) - China's Tibet Rhodiola Pharmaceutical Holding announced a deal on Wednesday to manufacture, sell and test Russia's COVID-19 vaccine in China, hours after interim results ...
China's Rhodiola set to sell and test Russia's Sputnik-V vaccine
HONG KONG/BEIJING (Reuters) - China's Tibet Rhodiola Pharmaceutical Holding announced a deal on Wednesday to manufacture, sell and test Russia's COVID-19 vaccine in China, hours after interim results ...
Get Tibet Rhodiola Pharmaceutical Holding Co fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
